MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Constipation in Early-Onset Parkinson’s Disease: frequency, time of onset and association with mortality

    C. Piat, A. Mullan, K. Ghoniem, P. Turcano, J. Bower, E. Benarroch, R. Savica (Rochester, USA)

    Objective: We aimed to determine the frequency, time of onset and mortality association of constipation in patients with Early-Onset Parkinson’s Disease (EOPD). Background: Constipation is…
  • 2024 International Congress

    Assessment of pain in people with Parkinson’s disease: an exploratory survey of international nursing experiences

    C. Tedesco, M. Petralito, R. Caruso, G. Pucciarelli (Rome, Italy)

    Objective: To explore the methods and tools used by PDNS to assess pain, as well as the main indicators, barriers and difficulties in its evaluation.…
  • 2024 International Congress

    Neuropathological Synergy in Cauda Equina Syndrome, Parkinson’s Disease, And Depression: Breaking the Dysphoric Cycle

    R. Grace, L. Velez, R. Islam, B. Carr (Gainesville, USA)

    Objective: This study endeavors to understand the intricate pathophysiological interactions among concurrent manifestations of cauda equina syndrome, Parkinson’s Disease (PD), and depression, with the objective…
  • 2024 International Congress

    Outcomes in Patients with Parkinsonism Treated for Acute Agitation with Intravenous Benzodiazepines Compared to Parenteral Antipsychotics While Inpatient

    A. Kundrick, C. Piccinin, J. Yu, P. Clark, S. Shaffer, O. Hogue, C. Sonneborn, B. Sokola, S. Sperling, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether patients with parkinsonism and severe agitation while inpatient have better outcomes when treated with parenteral benzodiazepines instead of parenteral antipsychotics. Background:…
  • 2024 International Congress

    Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol

    H. Hikichi, H. Nishijima, F. Mori, I. Kinoshita, C. Murakami, M. Tomiyama (Hirosaki, Japan)

    Objective: To reproduce the side effects of antipsychotic drugs (drug-induced Parkinsonism and tardive dyskinesia) in rats and elucidate its pathomechanism by examining morphological changes in…
  • 2024 International Congress

    Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.

    N. Guragain, P. Gyawanli, A. Mudvari, P. Prasad, R. Ghimire, B. Gajurel, R. Ojha (Kathmandu, Nepal)

    Objective: To assess the prevalence of movement disorders in epilepsy patients taking antiepileptics drugs. Background: A prospective longitudinal observational study was conducted for one year…
  • 2024 International Congress

    Predicting the Risk of Parkinson’s Disease by Body Composition and Metabolic Diseases in Gender and Age Dependent Manners

    J. Fu, H. Shang, X. Chen (Chengdu, Sichuan, China)

    Objective: Objective: This study intends to analyze the impact of body composition and metabolic diseases on the risk of Parkinson's disease (PD) using large-scale longitudinal…
  • 2024 International Congress

    Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study

    M. Park, K. Baik, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)

    Objective: To investigate whether usage of dipeptidyl peptidase IV inhibitors (DPP4i) is associated decreased mortality in Parkinson’s disease (PD). Background: Type 2 diabetes mellitus (T2DM)…
  • 2024 International Congress

    Correlation of Clinical Rating Scale for Tremor with Global Assessment

    S. Howard, S. Singh, D. Macaluso, J. Hsu, I. Cajigas, L. Qiu, C. Halpern, W. Aamodt, J. Farrar (Philadelphia, USA)

    Objective: Objective: The objective was to determine the association of the Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (CRST) scores with the CRST global assessment. Background:…
  • 2024 International Congress

    The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study

    M. Dumican, T. Reyers, A. Malczewski (Kalamazoo, USA)

    Objective: The objectives of this project were twofold: 1. Determine how genotypes of Parkinson’s Disease (PD) affect voice & swallowing function, and 2. Examine how…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley